Analysen von James Gordon
| 09.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.03.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 02.03.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 31.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.01.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 12.01.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 11.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.12.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.11.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 17.11.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 14.11.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 10.11.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.11.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.10.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 26.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.10.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 17.10.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 07.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.09.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 26.09.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 15.09.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 15.09.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.08.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 10.08.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 09.08.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.08.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.08.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 28.07.22 | GlaxoSmithKline Neutral | JP Morgan Chase & Co. | |
| 26.07.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 25.07.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.07.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 14.07.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.07.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.07.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.07.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.06.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 15.06.22 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 10.06.22 | GSK Neutral | JP Morgan Chase & Co. | |